Clinical Trials in San Francisco

Showing 3961-3980 of 12,991 trials

Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies

NCT05191472

This phase II trial tests whether pembrolizumab works to shrink tumors in patients with multiple myeloma whose cancer has come back (relapsed) or did not respond to previous treatment (refractory) with anti-BCMA CAR-T therapies. Immunotherapy with pembrolizumab, may induce changes in body's immune system and may interfere with the ability of cancer cells to grow and spread.

Multiple MyelomaMultiple Myeloma in RelapseMultiple Myeloma, Refractory+2 more

Alfred Chung, MD3 participantsStarted May 2022

San Francisco, California, United States

COMPLETEDPhase 2< 1 mile

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

NCT05203341

The purpose of this study is to evaluate the efficacy of NBI-1065845 compared with placebo in participants with MDD on improving symptoms of depression.

Major Depressive Disorder

Neurocrine Biosciences183 participantsStarted Feb 2022

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Riverside, California, United States +38 more locations

Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

Find Trials by Condition in San Francisco

Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer

Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed

Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma

A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

The Syn-Sleep Study

PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection

Nemaline Myopathy Clinical Research Network (NM-CTRN)

Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma

A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)

Safety and Efficacy of XT-150 for Facet Joint Osteoarthritis Pain

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies

Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)

Phase 4 Comparative Trial of Benzathine Penicillin G for Treatment of Early Syphilis in Subjects With or Without HIV Infection